Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan ; day:6 ; month:3 ; year:2017 ; pages:1-12
Osteoporosis international ; (6.3.2017), 1-12
- Schlagwort
-
Orthopädie
- Urheber
-
Moriwaki, K.
- Beteiligte Personen und Organisationen
-
Mouri, M.
Hagino, H.
SpringerLink (Online service)
- DOI
-
10.1007/s00198-017-3973-8
- URN
-
urn:nbn:de:1111-2017041911728
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moriwaki, K.
- Mouri, M.
- Hagino, H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia
Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
The effectiveness of intravenous zoledronic acid in elderly patients with osteoporosis after rotator cuff repair: a retrospective study
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia
Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
The effectiveness of intravenous zoledronic acid in elderly patients with osteoporosis after rotator cuff repair: a retrospective study
Treatment responses with once-weekly teriparatide therapy for osteoporosis
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia
Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
The effectiveness of intravenous zoledronic acid in elderly patients with osteoporosis after rotator cuff repair: a retrospective study
Treatment responses with once-weekly teriparatide therapy for osteoporosis